Aura Biosciences, Inc. (AURA)
6.35
+0.05
(+0.79%)
USD |
NASDAQ |
Oct 28, 15:14
Aura Biosciences Price : 6.35 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 6.20 | 6.31 | 6.095 | 6.30 | 680261.0 |
| Oct 26, 2026 | 6.31 | 6.42 | 6.145 | 6.18 | 907585.0 |
| Oct 23, 2026 | 6.33 | 6.40 | 6.16 | 6.30 | 722144.0 |
| Oct 22, 2026 | 6.46 | 6.59 | 6.35 | 6.46 | 955317.0 |
| Oct 21, 2026 | 6.46 | 6.61 | 6.385 | 6.46 | 933595.0 |
| Oct 20, 2026 | 6.32 | 6.77 | 6.18 | 6.56 | 1.164M |
| Oct 19, 2026 | 6.13 | 6.37 | 6.12 | 6.29 | 556795.0 |
| Oct 16, 2026 | 6.31 | 6.355 | 6.095 | 6.10 | 762494.0 |
| Oct 15, 2026 | 6.23 | 6.415 | 6.17 | 6.34 | 604522.0 |
| Oct 14, 2026 | 6.21 | 6.28 | 6.085 | 6.17 | 1.010M |
| Oct 13, 2026 | 6.53 | 6.56 | 6.18 | 6.27 | 1.663M |
| Oct 12, 2026 | 6.55 | 6.70 | 6.50 | 6.54 | 613138.0 |
| Oct 09, 2026 | 6.48 | 6.70 | 6.46 | 6.54 | 962557.0 |
| Oct 08, 2026 | 6.41 | 6.61 | 6.36 | 6.505 | 1.692M |
| Oct 07, 2026 | 6.10 | 6.563 | 6.10 | 6.46 | 723720.0 |
| Oct 06, 2026 | 6.26 | 6.27 | 6.10 | 6.17 | 607526.0 |
| Oct 05, 2026 | 6.09 | 6.42 | 6.05 | 6.22 | 589814.0 |
| Oct 02, 2026 | 6.11 | 6.15 | 5.97 | 6.09 | 2.099M |
| Oct 01, 2026 | 6.36 | 6.36 | 6.00 | 6.04 | 807346.0 |
| Sep 30, 2026 | 6.21 | 6.36 | 6.12 | 6.28 | 677458.0 |
| Sep 29, 2026 | 6.13 | 6.175 | 6.04 | 6.15 | 795446.0 |
| Sep 28, 2026 | 6.03 | 6.17 | 6.00 | 6.15 | 483658.0 |
| Sep 25, 2026 | 6.18 | 6.18 | 5.985 | 6.00 | 1.117M |
| Sep 24, 2026 | 6.01 | 6.25 | 5.95 | 6.15 | 963076.0 |
| Sep 23, 2026 | 6.42 | 6.470 | 5.98 | 6.02 | 1.037M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 59.26 |
| Oncolytics Biotech, Inc. | 0.434 |
| Sangamo Therapeutics, Inc. | 0.1181 |
| Sarepta Therapeutics, Inc. | 18.96 |
| Anixa Biosciences, Inc. | 3.35 |
Price Related Metrics
| Price to Book Value | 2.084 |
| Earnings Yield | -28.01% |
| Market Cap | 657.10M |